ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2014
Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.
Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Systematic review and standardized comparison of health-related quality-of-life instruments available for patients with oral cavity cancer and oropharyngeal cancer.BMC oral health · 2025Pooled it
- Pooled it
- Assessing oral health-related quality of life in children and adolescents: a systematic review and standardized comparison of available instruments.Clinical oral investigations · 2019Pooled it
- Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO.Renal failure · 2018Pooled it
- Constant-Murley Score: systematic review and standardized evaluation in different shoulder pathologies.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2018Pooled it
- The quality of systematic reviews of health-related outcome measurement instruments.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2016Pooled it
- Post-treatment changes in bowel and urinary function in prostate cancer patients treated with moderate or ultra-hypofractionation: A prospective cohort study.Clinical and translational radiation oncology · 2025Article
- Translation and investigation of the psychometric properties of the revised female sexual distress scale among Iranian couples.Scientific reports · 2025Article
- External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study.BMC cancer · 2025Article
- Assessing the parent-infant relationship: a two-stage, COSMIN-informed systematic review evaluating clinician-rated measures.Frontiers in psychiatry · 2025Review
- The Romanian translation and validation of the Extended Prostate Cancer Index Composite in patients undergoing radical prostatectomy.Medicine and pharmacy reports · 2024Article
- Construction for the predictive model of quality of life in patients after robot-assisted radical prostatectomy: a cohort study.International journal of medical sciences · 2024Article
- Psychometric validation of the Spanish version of the Expanded Prostate Cancer Index Composite-26.World journal of urology · 2023Article
- Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer.BMC cancer · 2023Article
- Evaluating Self-Concept Measurements in Adolescents: A Systematic Review.Children (Basel, Switzerland) · 2023Review
- Validation of the Brazilian Version of Functional Assessment of Cancer Therapy-Prostate-FACT-P (Version 4) in Prostate Cancer Patients.Journal of cancer education : the official journal of the American Association for Cancer Education · 2022Article
- Comprehension, utility, and preferences of prostate cancer survivors for visual timelines of patient-reported outcomes co-designed for limited graph literacy: meters and emojis over comics.Journal of the American Medical Informatics Association : JAMIA · 2022Article
- What is the Most Valid and Reliable Compassion Measure in Healthcare? An Updated Comprehensive and Critical Review.The patient · 2022Review
- Implementation of patient-reported outcome measures into health care for men with localized prostate cancer.Nature reviews. Urology · 2022Review
- A Comprehensive Evaluation of Health-Related Life Quality Assessment Through Head and Neck, Prostate, Breast, Lung, and Skin Cancer in Adults.Frontiers in public health · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeThe objective was to obtain a standardized evaluation of available prostate cancer-specific quality of life instruments used in patients with early-stage disease.
methodsWe carried out systematic literature reviews in the PubMed database to identify manuscripts which contained information regarding either the development process or metric properties of prostate cancer-specific quality of life instruments. Each instrument was evaluated by two experts, independently, using the Evaluating Measures of Patient-Reported Outcomes (EMPRO) tool. An overall and seven attribute-specific EMPRO scores were calculated (range 0-100, worst to best): measurement model, reliability, validity, responsiveness, interpretability, burden and alternative forms.
resultsEight instruments and 57 manuscripts (2-15 per instrument) were identified. The Expanded Prostate Cancer Index Composite (EPIC) was the best rated (overall EMPRO score 83.1 points). Good results were also obtained by University of California Los Angeles-Prostate Cancer Index (UCLA-PCI), Patient-Oriented Prostate Utility Scale (PORPUS) and Prostate Cancer Quality of Life Instrument (PC-QoL) with 77.3, 70.5 and 64.8 points, respectively. These four instruments passed with distinction the validity and responsiveness evaluation. Insufficient reliability results were observed for UCLA-PCI and PORPUS.
conclusionsCurrent evidence supports the choice of EPIC, PORPUS or PC-QoL. Attribute-specific EMPRO results facilitate selecting the adequate instrument for every purpose. For longitudinal studies or clinical trials, where responsiveness is the priority, EPIC or PC-QoL should be considered. We recommend the PORPUS for economic evaluations because it allows cost-utility analysis, and EPIC short versions to minimize administration burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.